Johns Hopkins Medicine researchers have shown that three doses of vaccine against SARS-CoV-2 — the virus that causes COVID-19 — increase antibody levels more than the standard two-dose regimen for people who have received solid organ transplants. The researchers say this finding suggests booster doses should be investigated for those who are immunocompromised. Read more from Johns Hopkins Medicine here.
